Trademark: 97271346
Word
STENVIZY
Status
Pending
Status Code
731
Status Date
Tuesday, February 27, 2024
Serial Number
97271346
Mark Type
4000
Filing Date
Thursday, February 17, 2022
Published for Opposition
Tuesday, February 28, 2023

Trademark Owner History
Beigene, Ltd. - Owner At Publication

Classifications
5 Medicines, pharmaceutical preparations, chemico-pharmaceutical preparations, biological preparations for medical purposes, chemical preparations for medical purposes, all of the foregoing for the treatment of cancer and rheumatoid arthritis; diagnostic biomarker reagents for medical purposes; pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases and infectious diseases

Trademark Events
Feb 28, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 27, 2024
Sou Extension 2 Granted
Feb 27, 2024
Sou Extension 2 Filed
Feb 27, 2024
Sou Teas Extension Received
May 12, 2023
Notice Of Approval Of Extension Request E-Mailed
May 10, 2023
Sou Extension 1 Granted
May 10, 2023
Sou Extension 1 Filed
May 10, 2023
Sou Teas Extension Received
Apr 25, 2023
Noa E-Mailed - Sou Required From Applicant
Feb 28, 2023
Official Gazette Publication Confirmation E-Mailed
Feb 28, 2023
Published For Opposition
Feb 8, 2023
Notification Of Notice Of Publication E-Mailed
Jan 24, 2023
Approved For Pub - Principal Register
Dec 8, 2022
Teas/Email Correspondence Entered
Dec 7, 2022
Correspondence Received In Law Office
Dec 7, 2022
Teas Response To Office Action Received
Dec 8, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Dec 8, 2022
Teas Change Of Correspondence Received
Dec 8, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 8, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 8, 2022
Teas Change Of Owner Address Received
Dec 2, 2022
Notification Of Non-Final Action E-Mailed
Dec 2, 2022
Non-Final Action E-Mailed
Dec 2, 2022
Non-Final Action Written
Dec 2, 2022
Assigned To Examiner
Feb 23, 2022
New Application Office Supplied Data Entered
Feb 21, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24